Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001568605-25-000005
Filing Date
2025-12-05
Accepted
2025-12-05 17:04:09
Documents
2
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 17951
2 WYRICK POA wyrickpoax.txt EX-24 3497
  Complete submission text file 0001568605-25-000005.txt   22905
Mailing Address 188 E. BLAINE STREET SUITE 400 SEATTLE WA 98102
Business Address
Wyrick Susan D. (Reporting) CIK: 0001568605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 251553733

Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)